Skip to main content

Prognostic value of upar forms in colon and breast cancer

Objective

Investigation of the clinical prognostic value of soluble urokinase plasminogen activator receptor (uPAR) forms in blood and tissue extracts from patients with colon and breast cancer, aiming to develop new methods which will aid in the decision-making needed in the management of cancer patients.

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

COPENHAGEN UNIVERSITY HOSPITAL
Address
Stransboulevarden 49
2100 Koepenhagen
Denmark